
His Pharmaceutical Private Limited
About His Pharmaceutical Private Limited
Data last updated:
His Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 May 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PTC068646. Its GSTIN is 07AAACH4301C1ZD (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹19.9 Lakh. It is led by directors Darpan Arora and Shiv Kumar Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 2A/264 Category – Lig First Floor Janakpuri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.14 Lakh, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹20.88 Lakh and EBITDA of -₹3.64 Lakh (EBITDA margin -169.6%). Revenue has declined at a compounded annual rate (CAGR) of 68% over three years and 42% over five years.
As per MCA filings, the company has open charges of ₹1 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
His Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 2A/264 Category – Lig First Floor Janakpuri, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of His Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of His Pharmaceutical is manufacturing. In detail, this covers manufacture of wearing apparel.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 14 | Manufacture of wearing apparel |
To see the full business activity and turnover split of His Pharmaceutical Private Limited, buy the company report.
Financials of His Pharmaceutical Private Limited
FY 2025 filings availableHis Pharmaceutical Private Limited reported revenue of ₹2.14 Lakh (down 84% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 42% over five years, including a 84% fall in the latest year. EBITDA fell 692% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹20.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -169.6% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of His Pharmaceutical Private Limited, buy the company report.
Board of directors of His Pharmaceutical Private Limited
His Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Darpan Arora Also directs: Borage Herbals Private Limited | Director | 15 Nov 2002 | 23 Years 11 Months | Current |
| Shiv Kumar Arora | Director | 17 May 1995 | 31 Years 5 Months | Current |
Auditor
His Pharmaceutical Private Limited is audited by S K BHARDWAJ & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S K BHARDWAJ & ASSOCIATES | FY 2019 | 008429N |
Shareholding
The shareholding of His Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of His Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Mar 2015 | 10575258 | The Panipat Urban Cooperative Bank Limited | ₹40 Lakh | Open | |
| 25 Mar 2015 | 10575362 | The Panipat Urban Cooperative Bank Limited | ₹40 Lakh | Open | |
| 23 Apr 1999 | 90035184 | Oriental Bank of Commerce | ₹20 Lakh | Open |
To see the full charge records of His Pharmaceutical Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
His Pharmaceutical Private Limited has 5 court cases on record: 1 filed by His Pharmaceutical, 4 filed against it. 2 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 2 |
| High courts | 1 | 0 | 0 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panipat, Haryana | Appeal | Filed against the company by Ryddx Pharmetry Pvt. Ltd. | Pending |
| District court, Panipat, Haryana | Appeal | Filed against the company by an individual | Pending |
| High Court, HARYANA | Criminal miscellaneous application | Filed by the company against State of Haryana (Through Drugs Control Officer, Panipat) | Disposed |
| District court, Panipat, Haryana | Commercial suit | Filed against the company | Disposed |
To see the full case history of His Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for His Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
His Pharmaceutical has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACH4301C1ZD | Delhi | Active | 26 Jun 2019 |
| 06AAACH4301C1ZF | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of His Pharmaceutical Private Limited, buy the company report.
Recent activity
His Pharmaceutical Private Limited has 3 board changes on record since 1995: 2 appointments and 1 cessation. The latest: Darpan Shiv Kumar ceased to be Director on 15 May 2019.
Frequently asked questions
His Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 May 1995 (31+ years old) and is registered under CIN U74899DL1995PTC068646.
His Pharmaceutical has 2 current directors:
- Darpan Arora - Director
- Shiv Kumar Arora - Director
The latest financial statements of His Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of His Pharmaceutical is 07AAACH4301C1ZD, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAACH4301C1ZF (Haryana).
The CIN (Corporate Identification Number) of His Pharmaceutical is U74899DL1995PTC068646. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
His Pharmaceutical has 5 court cases on record: 1 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
His Pharmaceutical was incorporated on 17 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
Darpan Shiv Kumar ceased to be Director on 15 May 2019. Darpan Arora was appointed as Director on 15 Nov 2002. Shiv Kumar Arora was appointed as Director on 17 May 1995.
The registered office of His Pharmaceutical is at A – 2A264 Category – Lig First Floor Janakpuri, New Delhi, Delhi, India – 110058.
His Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

